Himalaya Nutravedics India IPO Listing: Shares Debut Above 15% Premium
- September 29, 2026
- Posted by: Lakshit Sharma
- Category: News
Himalaya Nutravedics India trades at Rs 122 on BSE SME, up 15.09%. Day high Rs 124.15. Issue price Rs 106. Subscribed 2.33 times overall. Issue size Rs 26.50 Cr.
Quick Answer
The Himalaya Nutravedics India IPO listing today saw the stock trading at Rs 122 on the BSE SME platform by mid morning, a 15.09 percent premium over its Rs 106 issue price, after touching a day high of Rs 124.15. The Hyderabad based Ayurvedic and nutraceutical products maker’s IPO was subscribed 2.33 times overall.
Himalaya Nutravedics India IPO Listing Today: The IPO closed subscription at 2.33 times overall on 24 September 2026, with QIBs at 1.00 times, NIIs at 3.58 times and retail investors at 2.56 times. Here is a recap of the offer itself, the terms of the Himalaya Nutravedics India IPO listing, and how the stock actually traded once it opened on 29 September.
Click Here – Get Free Investment Predictions
Himalaya Nutravedics India IPO Listing: Issue Details
Himalaya Nutravedics India Limited raised Rs 26.50 crore through an entirely fresh issue of 24,99,600 shares, with no offer for sale component. The issue listed on the BSE SME platform, with a tentative listing date of 29 September 2026. Bidding ran from 22 September 2026 to 24 September 2026, at a face value of Rs 10 per share and a price band of Rs 100 to Rs 106 per share.
| Particular | Detail |
|---|---|
| Allotment Date | 25 September 2026 |
| IPO Open Date | 22 September 2026 |
| IPO Close Date | 24 September 2026 |
| Issue Size | Rs 26.50 crore (24,99,600 shares) |
| Face Value | Rs 10 per share |
| Lot Size | 1,200 shares |
| Issue Price | Rs 106 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Listing Date | 29 September 2026 |
Check Live Stock Data on the Univest Screener
Himalaya Nutravedics India IPO Listing Price and Performance
Shares of the Himalaya Nutravedics India IPO listing touched a day high of Rs 124.15 on the BSE SME platform before easing to trade at Rs 122 by mid morning, still a healthy 15.09 percent above the Rs 106 issue price. Retail investors who received a two lot allotment of 2,400 shares, costing about Rs 2.54 lakh, saw the value of their holding rise by roughly Rs 38,400 at the Rs 122 mark.
About the Himalaya Nutravedics India IPO
Himalaya Nutravedics India Limited operates a single, integrated manufacturing facility in Hyderabad, Telangana, that produces Ayurvedic and nutraceutical products, and the company also undertakes third party manufacturing, handling formulation, packaging and dispatch based on client specifications. Allwin Securities is the market maker for the issue and Kfin Technologies is the registrar. Investors following the Himalaya Nutravedics India IPO listing can use this background to judge the business behind the strong debut.
Download the Univest iOS App or Univest Android App to track Himalaya Nutravedics India live share price after the Himalaya Nutravedics India IPO listing and get daily stock recommendations.
Himalaya Nutravedics India Limited Financials
Here is how Himalaya Nutravedics India Limited has performed financially over the last three fiscal years, useful context for anyone weighing the Himalaya Nutravedics India IPO listing.
| Year Ended | 31 Mar 2026 (Rs cr.) | 31 Mar 2025 (Rs cr.) | 31 Mar 2024 (Rs cr.) |
|---|---|---|---|
| Assets | 24.42 | 10.82 | 6.09 |
| Total Income | 43.12 | 21.00 | 14.43 |
| Profit After Tax | 7.39 | 2.23 | 0.43 |
| EBITDA | 8.10 | 2.99 | 0.94 |
| Net Worth | 16.38 | 6.75 | 1.34 |
| Total Borrowings | 5.13 | 1.76 | 3.24 |
Explanation
Total income more than doubled in FY26 to Rs 43.12 crore from Rs 21.00 crore in FY25, itself up sharply from Rs 14.43 crore in FY24. Profit after tax grew even faster, from just Rs 0.43 crore in FY24 to Rs 7.39 crore in FY26, a more than 17 fold rise across the two years. Return on net worth stood at a high 45.12 percent in FY26, though the company is coming off a very small base, which is worth keeping in mind after the Himalaya Nutravedics India IPO listing.
Grey market premium (GMP) is an unofficial, unregulated indicator for the Himalaya Nutravedics India IPO that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data around the Himalaya Nutravedics India IPO listing can go through other relevant sources, though such figures should never be the sole basis for an investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs
What was the Himalaya Nutravedics India IPO listing price?
Ans. The Himalaya Nutravedics India IPO listing touched a high of Rs 124.15 on the BSE SME platform and was trading at Rs 122 by mid morning, a 15.09 percent premium over the Rs 106 issue price.
Was the Himalaya Nutravedics India IPO listing a premium or a discount?
Ans. It was a strong premium listing. The Himalaya Nutravedics India IPO listing gained more than 15 percent over the issue price.
How much was the Himalaya Nutravedics India IPO subscribed?
Ans. The IPO was subscribed 2.33 times overall, with QIBs at 1.00 time, NIIs at 3.58 times, and retail investors at 2.56 times their respective quotas.
What is the issue price of the Himalaya Nutravedics India IPO?
Ans. The issue price was fixed at Rs 106 per share, the top of the Rs 100 to Rs 106 price band.
What is the lot size of the Himalaya Nutravedics India IPO?
Ans. The lot size was 1,200 shares, and retail investors needed a minimum of two lots, or 2,400 shares, costing about Rs 2,54,400 at the upper price band.
Who is the registrar for the Himalaya Nutravedics India IPO?
Ans. Kfin Technologies Limited is the registrar.
What does Himalaya Nutravedics India do?
Ans. Himalaya Nutravedics India manufactures Ayurvedic and nutraceutical products at its Hyderabad facility and also offers third party manufacturing, formulation, packaging and dispatch services to other brands.
Where can I track the Himalaya Nutravedics India share price now?
Ans. You can track it on the BSE SME platform, or through the Univest platform.
Should I hold shares after the Himalaya Nutravedics India IPO listing?
Ans. That depends on your own risk appetite and time horizon. Worth weighing the very small revenue and profit base against the sharp growth rate before deciding whether to hold or book profit after the Himalaya Nutravedics India IPO listing.